CRH (CRH) H2 2011 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2011 earnings summary
19 Nov, 2026Executive summary
Like-for-like sales rose 5% in 2011; growth was 5% in both H1 and H2, with a strong year-end finish aided by favorable weather.
Profit before tax after impairments increased 33% to €711m; EPS rose 35%.
EBITDA reached €1.66bn, ~3% above November guidance; pre-impairment profit before tax was €743m, €85m above guidance.
Resilient margins in Products and Distribution offset pressure in Materials; portfolio breadth helped sustain overall margin performance.
Financial highlights
Revenue increased 5% on both a like-for-like and reported basis.
Profit before tax before impairment was €743m versus €658m in 2010; post-impairment profit before tax was €711m, up 33%.
2011 tax charge was €114m; the effective rate was 16%, with one-off tax benefits contributing to the lower rate.
EPS increased 35%; the annual dividend was maintained at €0.625 per share.
Outlook and guidance
Assuming no major economic or energy-market dislocations, further like-for-like revenue growth and another year of progress were expected in 2012.
Targeted price increases remained a priority; European Materials aimed to repeat 2011 pricing progress, while its 2012 energy bill was expected to rise 1%–2%.
Group cost-saving benefits were expected to exceed €100m in 2012, split roughly equally between Europe and the Americas; some close-out costs could remain.
Net debt was expected to finish 2012 below 2011 levels before acquisitions, assuming CapEx broadly at the 2011 level; future acquisition spending was excluded.
Latest events from CRH
- Strong organic profit growth and cash generation cut year-end net debt below 3x EBITDA.CRH
H2 2015 - Strong growth and cash generation cut leverage to 1.7x while supporting further growth.CRH
H2 2016 - €3.3bn EBITDA, stronger margins and returns, and major acquisitions positioned for further growth.CRH
H2 2017 - U.S. momentum and cost actions supported 2013 progress as net debt fell EUR 519m.CRH
H2 2012 - H2 momentum improved as portfolio actions and disciplined investment set up a moderate 2014 recovery.CRH
H2 2013 - EBITDA rose 11% in 2014; 2015 priorities were growth, integration and debt reduction.CRH
H2 2014 - Cash discipline and cost savings steadied results as markets began to stabilize.CRH
H2 2010 - Q3 EBITDA held near prior year; FY26 guidance is $7.8B–$8.0B amid cost and residential headwinds.CRH
Q3 2026 - Q2 2026 saw strong growth, margin gains, and the Arcosa deal, supporting a positive outlook.CRH
Q2 2026